The phase 2B trial of vapendavir will use bioMérieux’s Biofire Spotfire panel—a CLIA-waived molecular test that detects rhinovirus—to confirm infections in COPD patients.
Read More
The test detects early albumin markers in urine within 10 minutes, targeting high-risk diabetes and hypertension patients.
Read More
Journal of Clinical Microbiology study validates accuracy, precision and operational usability of FDA-cleared sepsis diagnostic test.
Read More
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
Read More
The Coag-Sense PT/INR Monitoring System gains IVDR approval for home anticoagulation monitoring, marking the company’s European market entry.
Read More